• HubertManne
    link
    fedilink
    136 months ago

    “The new therapy involves programming the patient’s peripheral blood mononuclear cells, transforming them into “seed cells” to recreate pancreatic islet tissue in an artificial environment.”

    I don’t see anything for the other two questions though but being patient derived would seem to fix your number 2.

    • @Soulfulginger
      link
      English
      96 months ago

      Unfortunately, that doesn’t necessarily negate the requirement for immunosuppresors or some other kind of immuno protection. If it is Type 1 diabetes, the person originally became diabetic because the immune system saw certain markers on the beta cells (insulin producing cells) as a threat. So, if you recreate the beta cells, there is still a possibility that it will happen again. You are fighting your own immune system. Someone in our lab was studying encapsulation of cells to create a protective barrier around them for this very issue

      If the person was Type 2, this might be less of a risk since type 2 can also be due to high insulin resistivity. There are a lot of other factors involved, though, it’s not straightforward

    • @Zehzin
      link
      English
      16 months ago

      would seem to fix your number 2.

      Hehehehehe